Vol 4, No 2 (2012)
Mol Cell Pharmacol
Table of Contents
PharmSights
| Implications and Development of AHR-based Therapeutic Agents | Abstract PDF |
| Eun-Young Choi, Hyosung Lee, R.W. Cameron Dingle, Kyung Bo Kim, Hollie I. Swanson | 53-60 |
| A Main Role for Metabotropic Glutamate Receptor 1 in the Neuroprotective Effect of Estrogen | Abstract PDF |
| Simona Federica Spampinato, Sara Merlo, Ferdinando Nicoletti, Maria Angela Sortino | 61-67 |
Reviews
| Anticancer Activity and Molecular Mechanisms of Action of Makaluvamines and Analogues | Abstract PDF |
| Subhasree Nag, Dwayaja H. Nadkarni, Jiang-Jiang Qin, Sukesh Voruganti, Thao Nguyen, Su Xu, Wei Wang, Hui Wang, Sadanandan E. Velu, Ruiwen Zhang | 69-81 |
FDA Corner
| FDA Approves Varizig for Reducing Chickenpox Symptoms | Abstract PDF |
| 83 |
| FDA Approves Xeljanz for Rheumatoid Arthritis | Abstract PDF |
| 83-84 |
| FDA Approves Synribo for Chronic Myelogenous Leukemia | Abstract PDF |
| 84-85 |
| FDA Approves New Treatment for Advanced Colorectal Cancer | Abstract PDF |
| 85 |
Our partner: Crossroads Pharmacy 2800 Hwy 101, Rogersville, AL 35652 LumiText Publishing, P.O. Box 774, Ellicott City, MD 21041 Copyright © 2008 LumiText Publishing. All rights reserved.